I don’t have any additional information about this specific bill, but I’d guess that prevention of discrimination is exactly the point.
It seems to me it would prevent the use of QALYs for making decisions such as is a particular cure for blindness worthwhile,
Yeah, I think this is probably a good thing—QALY-based prices probably shouldn’t be used to determine “determine relevant thresholds for coverage, reimbursements, or incentive programs” (ETA: particularly for federal programs in a health care system like that in the US).
and how might it compare to treatments for other diseases and conditions.
I’m not sure this would come into play here, since insurance coverage etc. (which, to my understanding, is what is in question here) doesn’t operate with that logic, but I could be lacking in imagination.
I don’t have any additional information about this specific bill, but I’d guess that prevention of discrimination is exactly the point.
Yeah, I think this is probably a good thing—QALY-based prices probably shouldn’t be used to determine “determine relevant thresholds for coverage, reimbursements, or incentive programs” (ETA: particularly for federal programs in a health care system like that in the US).
I’m not sure this would come into play here, since insurance coverage etc. (which, to my understanding, is what is in question here) doesn’t operate with that logic, but I could be lacking in imagination.